Navigation Links
British Scientists Discover New Protein to Treat Epilepsy and Schizophrenia

Curbing excitation through suppressing communication between the cells could be one way of treating diseases such as epilepsy and schizophrenia.

Researchers at the University of Bristol seem to have pitched upon a protein that could do the trick. The SUMO protein acts to damp down the amount of information transmitted to cells.

And so boosting the level of the protein in the brain could the key to tackling diseases such as epilepsy and schizophrenia, the Bristol scientists think.

There are 100 million nerve cells in the brain, which each have 10,000 connections, called synapses, which link to other nerves cells.

These connections chemically transmit information that control brain function via proteins called receptors. These processes are believed to be the basis of learning and memory.

In a healthy brain, synapses can modify how efficiently they work, by increasing or decreasing the amount of information transmitted.

Having too much information is a problem, but so is having too little which can cause conditions including coma.

The researchers, who carried out work on rats, found that when one type of receptor, the kainate receptor, receives a chemical signal a small protein called SUMO attaches itself.

SUMO pulls the kainate receptor out of the synapse, stopping it from receiving information from other cells and making the cell less excitable.

The scientists who discovered SUMO's role say it is interesting because it means the receptor is not destroyed, but simply lies dormant, meaning the dangers of completely cutting off communication between cells should be avoided.

Professor Jeremy Henley, who led the research, said: "We have found one mechanism that regulates the flow of information between cells in the brain.

"It is possible that increasing the amount of SUMO attached to kainate receptors - which would red uce communication between the cells - could be a way to treat epilepsy by preventing over-excitation."

The researchers say that their findings could also provide insight into other brain diseases that are characterised by too much synaptic activity, like schizophrenia, which could one day lead to new drugs.

Professor Ley Sander, an epilepsy expert at the Institute of Neurology, said the work was at early stages but was interesting.

"This is an additional part of the puzzle and it is interesting to learn more about brain processes.

"But we are talking about five to 10 years if this is really going to make a big difference." Jo Loughran, of the mental health charity Rethink, said: "We welcome this exciting new research and hope that one day it could make a difference to the thousands of people living with severe mental illnesses like schizophrenia.

"We would like to see continued investment in such research that will lead to a third generation of antipsychotic medicines with fewer side effects."


Related medicine news :

1. Designer baby for British couple
2. British Authorities Seize Spurious Drugs
3. Collaborations planned between British Organization and Indian health care industry
4. British Healthcare Mission Explores Partnership Possibilities With Indian Healthcare Sector
5. British Women Flies to India for Treatment of Breast Cancer
6. Sharp Increase In Morning-After Pill Sales Among British Women
7. British company developing ‘Safer Cigarettes
8. British man Recovered from HIV
9. British medical education suffers shortage of bodies
10. Relief For British MS Patients: Cannabis-Based Oral Spray
11. British Scientists Doubt Delhi Doctor’s Stem Cell Claim
Post Your Comments:

(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on ... Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ability ... fumigation is not a common occurrence, but a necessary one in the event that lice ...
(Date:6/25/2016)... ... 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland ... iHire in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness ... & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of ...
(Date:6/24/2016)... PASADENA, CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. ... he would lash out at his family verbally and physically. , “When something upset him, ... table, he would use it. He would throw rocks at my other children and say ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief ... a minimum wage raise to $12 an hour by 2020 and then adjusting it yearly ... lost value of the minimum wage, assure the wage floor does not erode again, and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: